冠心病抗血小板治疗

被引:8
作者
韩雅玲
机构
[1] 沈阳军区总医院心内科
关键词
冠心病; 血小板; 阿司匹林; 氯吡格雷;
D O I
10.14010/j.cnki.wjyx.2006.03.002
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:163 / 165
页数:3
相关论文
共 10 条
[1]  
Terms andConditions:Semantic Complexity and Aspirin Resistance. Hennekens CH,Schror K,Weisman Set al. Circulation . 2004
[2]  
Global patterns of useof antithrombotic and antiplatelet therapies in patients withacute coronary syndromes:Insights from the Global Registryof Acute Coronary Events(GRACE). Budaj A,Brieger D,Steg PGet al. American Heart Journal . 2003
[3]  
Lack of AdverseClopidogrel-Atorvastatin Clinical Interaction From Sec-ondary Analysis of a Randomized,Placebo-ControlledClopidogrel Trial. Saw J,Steinhubl SR,Berger PBet al. Circulation . 2003
[4]  
Cilostazol forrestenosis trial:a randomized,double-blind study follow-ing coronary artery stent implantation.Late Breaking Clini-cal Trial Abstracts,AHA,2003. Douglas Jr JS,Holmes Jr DR,Kereiakes D. Circulation . 2003
[5]  
Improving theCare of Patients with Non-ST-elevation Acute CoronarySyndromes in the Emergency Department:The CRUSADEInitiative. Hoekstra JW,Pollack Jr CV,Roe MTet al. Academic Emergency Medicine . 2002
[6]  
A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk ofis-chaemic events. The CAPRIE Steering Committee. The Lancet . 1996
[7]  
Effects of pretreat-ment with clopidogrel and aspirin followed by long-termtherapy in patients undergoing percutaneous coronary inter-vention:the PCI-CURE study. Mehta SR,Yusuf S,Peters RJet al. The Lancet . 2001
[8]  
Atorvastatin re-duces the ability of clopidogrel to inhibit platelet aggrega-tion:a new drug-drug inte.raction. Lau WC,Waskell LA,Watkins PBet al. Circulation . 2003
[9]  
Early andsustained dual oral antiplatelet therapy following percuta-neous coronary intervention:a randomized controlled trial. Steinhubl SR,Berger PB,Mann JT 3rdet al. The Journal of The American Medical Association . 2002
[10]  
Effects of clopidogrel inaddition to aspirin in patients with acute coronary syndromeswithout ST-segment elevation. Yusuf S,Zhao F,Mehta SRet al. The New England Journal of Medicine . 2001